BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29282862)

  • 1. Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects.
    Dejardin D; Delmar P; Warne C; Patel K; van Rosmalen J; Lesaffre E
    Pharm Stat; 2018 Mar; 17(2):169-181. PubMed ID: 29282862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
    Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
    Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical controls in clinical trials: a note on linking Pocock's model with the robust mixture priors.
    Callegaro A; Galwey N; Abellan JJ
    Biostatistics; 2023 Apr; 24(2):443-448. PubMed ID: 37057610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian borrowing from historical control data in a vaccine efficacy trial.
    Peng L; Jin J; Chambonneau L; Zhao X; Zhang J
    Pharm Stat; 2023; 22(5):815-835. PubMed ID: 37226586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
    Ghosh S; Tiwari RC; Ghosh S
    Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group sequential design for historical control trials using error spending functions.
    Wu J; Li Y
    J Biopharm Stat; 2020 Mar; 30(2):351-363. PubMed ID: 31718458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
    Yuan J; Liu J; Zhu R; Lu Y; Palm U
    J Biopharm Stat; 2019; 29(3):558-573. PubMed ID: 30612514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
    Wang X; Suttner L; Jemielita T; Li X
    J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.
    Bennett M; White S; Best N; Mander A
    Pharm Stat; 2021 May; 20(3):462-484. PubMed ID: 33474798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified power prior with multiple historical trials for binary endpoints.
    Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
    Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single-arm vs. randomized phase II clinical trials: a Bayesian approach.
    Sambucini V
    J Biopharm Stat; 2015; 25(3):474-89. PubMed ID: 24896838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian adaptive design for covariate-adaptive historical control information borrowing.
    Jin H; Kim MO; Scheffler A; Jiang F
    Stat Med; 2023 Dec; 42(29):5338-5352. PubMed ID: 37750361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculation based on efficient unconditional tests for clinical trials with historical controls.
    Shan G; Moonie S; Shen J
    J Biopharm Stat; 2016; 26(2):240-9. PubMed ID: 25551261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
    Ohigashi T; Maruo K; Sozu T; Gosho M
    Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.